Clarithromycin Tablet, Film Coated
Product Images NDC 85766-197

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 85766-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2 (Clarithromycin Figure2)

This text provides information about the mean plasma concentration of Clarithromycin Extended-Release Tablets (2 x 500 mg q24h) and Clarithromycin Tablets (500 mg q12h) over a 24-hour period. The graph shows the time after dosing in hours.*

FDA Label Image

Figure 3 (Clarithromycin Figure3)

This appears to be a medication study graph showing the comparison between Clarithromycin and Placebo over a period of 700 days since randomization. The y-axis likely represents some measured parameter or outcome, while the x-axis denotes the days since randomization.*

FDA Label Image

Structure (Clarithromycin Structure)

FDA Label Image

250 (Label 250mg)

FDA Label Image

500 (Label 500mg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.